S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom

Halozyme Therapeutics (HALO) Insider Trading & Ownership

$38.02
-0.36 (-0.94%)
(As of 04/17/2024 ET)

Halozyme Therapeutics (NASDAQ:HALO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
2.70%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$6.52 M
Get HALO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Halozyme Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

HALO Insider Buying and Selling by Quarter

Halozyme Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/12/2024Michael J LabarreSVPSell10,000$41.64$416,400.00  
2/28/2024Michael J LabarreSVPSell10,000$39.55$395,500.00  
12/12/2023Michael J LabarreSVPSell10,000$39.63$396,300.00  
10/17/2023Michael J LabarreSVPSell10,000$36.52$365,200.00  
9/19/2023Michael J LabarreSVPSell10,000$39.10$391,000.00  
8/31/2023Helen TorleyCEOSell10,000$42.82$428,200.00  
8/29/2023Helen TorleyCEOSell10,000$42.40$424,000.00  
8/22/2023Michael J LabarreSVPSell10,000$42.41$424,100.00  
8/22/2023Michael J LabarreSVPSell10,000$42.41$424,100.00  
8/17/2023Helen TorleyCEOSell10,000$43.18$431,800.00  
8/14/2023James M DalyDirectorSell10,000$43.74$437,400.00  
8/11/2023James M DalyDirectorSell10,000$43.71$437,100.00  
7/26/2023Helen TorleyCEOSell10,000$42.69$426,900.00  
7/18/2023Michael J LabarreSVPSell10,000$40.43$404,300.00  
7/12/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Sell$37.19$15,001 - $50,000
6/21/2023Michael J LabarreSVPSell10,000$36.00$360,000.00  
4/18/2023Michael J LabarreSVPSell10,000$36.00$360,000.00  
(Data available from 1/1/2013 forward)

HALO Insider Trading Activity - Frequently Asked Questions

Who is on Halozyme Therapeutics's Insider Roster?
What percentage of Halozyme Therapeutics stock is owned by insiders?

2.70% of Halozyme Therapeutics stock is owned by insiders. Learn more on HALO's insider holdings.

Which Halozyme Therapeutics insiders have been selling company stock?

The following insiders have sold HALO shares in the last 24 months: Helen Torley ($5,270,664.86), James M Daly ($874,500.00), Jeffrey William Henderson ($477,100.00), Matthew L Posard ($1,145,400.00), Michael J Labarre ($6,548,900.00), and Nicole Labrosse ($393,431.50).

How much insider selling is happening at Halozyme Therapeutics?

Insiders have sold a total of 318,586 Halozyme Therapeutics shares in the last 24 months for a total of $14,709,996.36 sold.

Which members of congress are trading Halozyme Therapeutics?

Daniel S. Goldman (D-NY) has sold shares of Halozyme Therapeutics in the last year totaling $32,500.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:HALO) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners